Alnylam Pharmaceuticals | ALNY - 债务利息支出

股票价格

319.29

每天变化

-11.05 -3.35%

每月一次

-1.33%

每年

42.34%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.53B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	债务利息支出	更改		日
Acadia Pharmaceuticals	USD 0		4.12M	2024-09
Agios Pharmaceuticals	USD 1.39B		85.53M	2025-09
Alnylam Pharmaceuticals	USD 129.34M		84.94M	2025-12
Amgen	USD 653M		32M	2025-12
Arrowhead Research	USD 22.5M		811K	2025-12
BioCryst Pharmaceuticals	USD 14.14M		5.53M	2025-12
BioMarin Pharmaceutical	USD 2.78M		199K	2025-12
Incyte	USD 582K		10K	2025-12
Ionis Pharmaceuticals	USD 18M		0	2025-12
Moderna	USD 12.14B		12.13B	2025-09
Neurocrine Biosciences	USD 1.1M		0	2024-03
Novartis	USD 281M		8M	2025-09
PTC Therapeutics	USD 50.58M		2.59B	2025-12
Regeneron Pharmaceuticals	USD 12.2M		7.1M	2025-12
Sangamo BioSciences	97.56M		11.39M	2025-06
Sanofi	EUR -25M		99.78M	2025-12
Sarepta Therapeutics	USD 7.56M		2.33M	2025-09
Takeda	JPY 123.63B		40.49B	2025-12
Tectonic Therapeutic	USD 12K		276.99M	2025-12
Ultragenyx Pharmaceutical	USD 19M		4.85M	2025-12
Vertex Pharmaceuticals	USD 3.3M		0	2025-12
Xencor	USD 7.35M		311K	2025-12